Prostate cancer chemoprevention: models, limitations and potential (Review).

  • Authors:
    • Sanjay Gupta
  • View Affiliations

  • Published online on: October 1, 2004     https://doi.org/10.3892/ijo.25.4.1133
  • Pages: 1133-1181
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The silent course of prostate cancer and its fatal outcome have hindered the development of treatment options for this disease. There is a need for new options in the management of prostate cancer. Chemoprevention is a relatively new and promising strategy, employing natural or synthetic agents to delay, halt or even reverse the process of carcinogenesis. Numerous synthetic and naturally occurring compounds have been evaluated in cell culture systems and in vivo models of prostate cancer for possible use in cancer chemopreventive programs. Here, I provide a review of studies of chemopreventive/therapeutic agents in various models of prostate cancer.

Related Articles

Journal Cover

October 2004
Volume 25 Issue 4

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Gupta, S. (2004). Prostate cancer chemoprevention: models, limitations and potential (Review).. International Journal of Oncology, 25, 1133-1181. https://doi.org/10.3892/ijo.25.4.1133
MLA
Gupta, S."Prostate cancer chemoprevention: models, limitations and potential (Review).". International Journal of Oncology 25.4 (2004): 1133-1181.
Chicago
Gupta, S."Prostate cancer chemoprevention: models, limitations and potential (Review).". International Journal of Oncology 25, no. 4 (2004): 1133-1181. https://doi.org/10.3892/ijo.25.4.1133